Mangoceuticals, Inc.MGRXNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank25
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-3896.10%
↑ 32% vs avg
Percentile
P25
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-5706.36%
Historical baseline
PeriodValueYoY Change
TTM-3896.10%-201.4%
2024-1292.80%-16.8%
2023-1106.44%+95.0%
2022-22236.48%-
20210.00%-